QNRX

3.2802.35%
MM

Michael Myers

Co-Founder, CEO & Chairman

Dr. Michael Myers, Ph.D., has been an Independent Director at Squarex Pharmaceutical Corp., since November 2022. He serves as Chief Executive Officer and Chairman of Quoin Pharmaceuticals, Ltd. from October 28, 2021. Since 2022, Dr. Myers has served as a Director of Ethicann Pharmaceuticals. Dr. Myers is Co-Founder and Director of Quoin Pharmaceuticals, Inc. since March 2018. Dr. Myers has experience in the drug delivery and specialty pharmaceutical sectors. Dr. Myers has served Chief Executive Officer of Innocoll, Inc. and was responsible for taking that company public in 2014. Dr. Myers raised millions in public and private funding and was the inventor of Innocoll’s lead commercial product. He served as President of The Drug Delivery Division of West Pharmaceutical Services, President of Pharmaceutical Operations for Fuisz Technologies (Biovail) and has held executive positions in Flamel Technologies and Elan Corporation. Dr. Myers serves on the Board of Directors of Wellesley Pharmaceuticals, Venkor Pharmaceuticals and Sonoran Biosciences. He is listed as an inventor on numerous patents and has led the development and commercialization of a number of highly successful pharmaceutical products. Dr. Myers served as the Head of Portfolio Operations at Innocoll AG (formerly Innocoll GmbH) since December 08, 2014 and served as its Member of Management Board. Dr. Myers served as Executive Vice President of Flamel since May 11, 2000. Dr. Myers is responsible for its Sales, Marketing and Business Development. He served as the Chief Executive Officer of Innocoll AG from 2003 to December 08, 2014, and also served as its President and Chairman of Management Board. Dr. Myers served as an Executive Vice President and President of the Pharmaceutical Division at Biovail Technologies Limited (formerly, Fuisz Technologies Ltd.) since April 1996. He joined Fuisz Technologies Ltd. in November 1995 as Vice President, Sustained Release. At Fuisz, he led day to day and strategic operations, in addition to business development activities, R&D, manufacturing quality operations and regulatory affairs. From 1987 to 1995, he served for Elan Corporation PLC, a leading drug delivery company, as Head of Pharmaceutical Development. He also served senior R&D positions at Kos Pharmaceuticals. He served as a Director of Innocoll, Inc. Dr. Myers received his Ph.D. in Organic Chemistry and B.Sc. from University College, Cork, Ireland.

Positions